Regulatory Collaboration as a Catalyst for Global Public Health

Excellence in the regulation of medicines and medical technologies is a cornerstone of global public health protection and societal trust. In an era defined by rapid scientific and technological advancement, the regulatory landscape must evolve to keep pace with breakthroughs spanning medicine, pharmacology, basic science, and engineering. While these developments promise to transform healthcare, they also introduce complexity and uncertainty, accentuating the necessity for robust and adaptive regulatory frameworks. Ongoing debates highlight the uneven pace of regulatory innovation worldwide and the challenges in harmonizing standards across borders. There is however a growing consensus that effective collaboration among regulators within and across countries, and between regulators and other public and private stakeholders, is fundamental for safeguarding public health while enabling timely access to innovations. Yet, significant gaps persist in our knowledge of how diverse forms of regulatory cooperation translate into measurable improvements in regulatory science and practice, particularly in response to a fast-changing global health landscape.This Research Topic aims to highlight, analyze, and disseminate evidence on the value and modalities of collaboration among regulatory authorities and their partners in the pharmaceutical and medical technology sectors. It seeks to answer critical questions about how strategic cooperation catalyzes regulatory excellence, fosters knowledge sharing, and accelerates the introduction of safe and effective health solutions. The initiative also encourages examination of the hurdles, enablers, and tangible outcomes associated with various models of collaboration, both national and international. By assembling a diverse set of contributions, the research topic intends to deepen the understanding of the crucial role played by regulatory led efforts in navigating complex scientific, health, and political environments.The scope of this Research Topic encompasses national and international regulatory collaborations, focusing on interactions that advance regulatory science and improve public health outcomes. It welcomes contributions that document, analyze, or propose novel and effective collaborative approaches across diverse contexts. To gather further insights in this area, we welcome articles addressing, but not limited to, the following themes:• Case studies of successful regulatory collaboration at national, regional, or international levels• Impact of collaborative platforms, consortia, and networks on regulatory capacity and outcomes• Innovative models for resource, data, and expertise sharing among regulatory stakeholders• The influence of strategic partnerships on regulatory agility in response to emerging health threats• Lessons learned from established or pilot initiatives and their implications for future regulatory policyWe encourage the submission of review articles detailing relevant examples of regulatory interactions, as well as original research papers that describe specific collaborative projects or out-of-the-box approaches enhancing regulatory cooperation. Topic editors: Daniel O'Connor, Armando Magrelli, Violeta Stoyanova-Beninska Source: https://www.frontiersin.org/research-topics/78393/regulatory-collaboration-as-a-catalyst-for-global-public-health